A
Astria Therapeutics
ATXS
11.200
USD
-0.49
(-4.19%)
مغلق
حجم التداول
17,388
الربح لكل سهم
0
العائد الربحي
0
P/E
-5
حجم السوق
639,862,698
العنوان: Astria Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment ofatopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.